Related Experiment Video
Updated: Apr 24, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
[Motivation of High-risk Patients to Stop Smoking in the DMP]
M Bleckwenn1, S Münster1, K Weckbecker1
1Institut für Hausarztmedizin, Unikliniken Bonn, Bonn.
Insights
Integrating ARRBIA heart into disease management programmes (DMP) is feasible for cardiovascular risk reduction. While a single intervention didn't change smoking behavior, it increased risk perception and motivation to quit.
Area of Science:
- Cardiology
- Public Health
- Behavioral Science
Background:
- Patients in disease management programmes (DMP) exhibit high cardiovascular risk.
- Smoking is a primary preventable risk factor for cardiovascular disease.
- Previous studies suggest multiple risk factor interventions can reduce overall risk.
Purpose of the Study:
- To assess the feasibility of integrating the ARRBIA heart risk calculator into DMPs.
- To evaluate the potential of ARRBIA heart to increase patient motivation for smoking cessation.
- To investigate the impact of risk consulting on smoking behavior within DMPs.
Main Methods:
- The MOTOR study involved 47 patients receiving risk consulting with ARRBIA heart and a smoking cessation intervention.
- A control group of 33 patients received usual DMP care.
- Interventions were tailored to patient motivation stages, with self-help materials provided.
Main Results:
- ARRBIA heart integration into DMPs is feasible, requiring an average of 10 minutes per consultation.
- Most physicians expressed willingness to continue using ARRBIA heart.
- A single risk consulting session did not significantly alter smoking behavior but increased risk perception and motivation to quit.
Conclusions:
- Integrating ARRBIA heart into DMPs is a viable strategy for delivering regular smoking brief interventions.
- Further research is needed to evaluate the effectiveness of multiple risk consulting sessions on smoking behavior and overall cardiovascular risk.
- The study highlights the potential of risk calculators in motivating smoking cessation within chronic disease management.
Aim Of The Study:
Patients in disease management programmes (DMP) have a high overall cardiovascular risk. Smoking is the most important preventable risk factor. A reduction in the overall risk could be achieved in studies by multiple risk consulting. Direct influence on the smoking behaviour has not been investigated. ARRBIA heart is a risk calculator that can represent mainly the possible risk reduction through a change in behaviour such as smoking cessation. The MOTOR study should therefore review the possibility of integrating ARRBIA heart DMP in order to increase the motivation to stop smoking.
Methodology:
As part of the usual consultation DMP 47 patients were informed about their personal overall cardiovascular risk. Then a smoking brief intervention was performed depending on the predetermined motivation stage and handed out in a self-help manual at the end of the consultation. In the control group, 33 patients were treated as usual in the DMP.
Results:
The integration of a risk consulting with ARRIBA heart is possible at a mean intervention period of 10 min in the regular DMP. Most doctors want to continue to work with ARRIBA heart. A change in smoking behaviour could not be determined by a single risk consulting. It was found, however, that the perception of risk increased with increasing motivation to stop smoking.
Conclusions:
In a subsequent study, the effectiveness of multiple risk consulting on the smoking behaviour and the overall risk must now be checked. The integration of ARRIBA heart is a possible approach to achieve regular smoking brief interventions in the DMP.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Stress Prevention and Stress Management Techniques IV
COPD: Management Using Bronchodilators and Corticosteroids
Atherosclerosis III: Management
Stress Prevention and Stress Management Techniques VI
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...